Group 1 - The core viewpoint of the news is that Zhonghong Medical has experienced fluctuations in its stock performance and financing activities, indicating a high level of trading activity and potential investor interest [1][2]. - On November 21, Zhonghong Medical's stock fell by 2.39%, with a trading volume of 259 million yuan. The net financing purchase on that day was 1.21 million yuan, with a total financing and securities balance of 128 million yuan [1]. - The financing balance of Zhonghong Medical is currently at 128 million yuan, accounting for 2.08% of its market capitalization, which is above the 90th percentile level over the past year, indicating a high level of financing activity [1]. Group 2 - As of September 30, Zhonghong Medical reported a total of 22,400 shareholders, an increase of 11.24% from the previous period, while the average circulating shares per person decreased by 10.11% to 17,531 shares [2]. - For the period from January to September 2025, Zhonghong Medical achieved a revenue of 1.864 billion yuan, representing a year-on-year growth of 1.38%. However, the net profit attributable to the parent company was -7.21 million yuan, a decrease of 114.13% year-on-year [2]. - Since its A-share listing, Zhonghong Medical has distributed a total of 1.251 billion yuan in dividends, with 501 million yuan distributed in the last three years [3].
中红医疗11月21日获融资买入2237.98万元，融资余额1.28亿元